NUTX Stock: Price, Earnings History and SEC Filings
Nutex Health Inc. (NUTX) last traded at $200.15, down 4.74% on the latest session and down 5.4% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $9.58 against an analyst estimate of $5.26, a beat of 82.1%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
NUTX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $9.58 | $5.26 | +82.13% |
NUTX beat the analyst EPS estimate in 1 of its last 1 reported quarters. Source: Nasdaq.
How NUTX reacts to earnings
Across its last 8 earnings releases, NUTX moved 14.4% on average the next session, in either direction. It rose after 6 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-06 | After close | +6.67% |
| 2026-04-30 | After close | +17.09% |
| 2026-03-05 | After close | -14.30% |
| 2025-11-19 | After close | +26.87% |
| 2025-11-18 | After close | +13.09% |
| 2025-10-20 | Before open | +17.05% |
| 2025-08-20 | After close | +3.70% |
| 2025-08-14 | After close | -16.40% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
NUTX financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $875M | $71M | $246M | 8.1% | $10.48 |
| 2024 | $480M | $52M | $21M | 10.9% | $9.69 |
| 2023 | $248M | -$46M | -$8M | -18.5% | $-10.39 |
| 2022 | $219M | -$425M | $36M | -193.7% | $-100.36 |
| 2021 | $332M | $133M | $137M | 40.0% | $0.22 |
| 2020 | $274M | $106M | $25M | 38.7% | $0.18 |
| 2019 | $1M | -$7M | -$4M | -520.8% | – |
| 2018 | $1M | -$950129 | -$480049 | -69.5% | – |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for NUTX
- 8-K · Sep 11, 2026Other events, Financial statements and exhibits
- 8-K · Aug 31, 2026
- 8-K · Aug 24, 2026Other events
- 8-K · Aug 13, 2026Other events
- 8-K · Aug 6, 2026Results of operations, Financial statements and exhibits
- 10-Q · Aug 6, 2026
- 8-K · Jul 21, 2026Material agreement
- 8-K · Apr 30, 2026Results of operations, Financial statements and exhibits
- 10-Q · Apr 30, 2026
- 8-K · Apr 23, 2026Shareholder vote
Insider filing activity
NUTX insiders filed 1 Form 4 report in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
NUTX news
- Nutex Health Schedules 2026 Third Quarter Financial Results Release and Conference CallOct 19, 2026 · finance.yahoo.com
About Nutex Health Inc.
Nutex Health Inc. (NUTX) is a US-listed public company on Nasdaq. The SEC classifies its business as Services-business Services NEC. It is incorporated in DE. Its fiscal year ends in December.